EMA to study potential vaccine for Lyme disease
European regulators begin evaluation of a vaccine candidate for the tick-borne illness, which currently has no approved preventive treatment.
What to know
- EMA is studying a vaccine candidate for Lyme disease, the most common tick-borne illness.
- No approved vaccine for Lyme disease currently exists in the EU.
- The regulatory evaluation represents progress toward filling a significant gap in preventive treatment options.
“The most common tick-borne illness currently has no approved vaccine”
Euractiv Economy · Mastodon
European Medicines Agency (EMA) Regulatory authority
The record 4 articles and posts · last 30 days
What people are saying 3 voices from 1 site · verbatim
- Aug 14
-
C
EU to study potential vaccine for Lyme disease, AFP reports. This article and more at canadahealthwatch.ca #LymeDisease #CdnHealth
-
E
EMA to study potential vaccine for Lyme disease https://www. euractiv.com/news/ema-to-study -potential-vaccine-for-lyme-disease/?utm_source=eac&utm_medium=mastodon&utm_campaign=%40euractiv_health%40eupolicy.social
-
E
EMA to study potential vaccine for Lyme disease: The most common tick-borne illness currently has no approved vaccine https://www. euractiv.com/news/ema-to-study -potential-vaccine-for-lyme-disease/?utm_source=eac&utm_medium=mastodon&utm_campaign=%40euractiv_economy%40eupolicy.social